Growth Hormone Deficiency clinical trials at UCSF
2 research studies open to eligible people
Growth hormone deficiency occurs when the body lacks sufficient growth hormone. UCSF is researching the safety of a medicine called lonapegsomatropin in patients treated with it. Additionally, UCSF is studying the long-term effectiveness and safety of using SKYTROFA.
Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
open to eligible people ages 1-18
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
San Francisco 5391959, California 5332921 and other locations
US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
open to eligible people ages 1-18
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
San Francisco 5391959, California 5332921 and other locations
Last updated: